VistaGen Therapeutics, Inc. ( VTGN) - Stock Earnings
VTGN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| June 16, 2026, midnight | — / — | — | — / — | — |
| July 1, 2026, midnight | — / — | — | — / — | — |
VTGN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -15.1 million USD | 244000 USD |
| 2025Q3 | -19.4 million USD | 258000 USD |
| 2025Q4 | -18.9 million USD | 303000 USD |
VTGN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -59.2 million USD | -227300 USD |
| 2024 | -29.4 million USD | 1.1 million USD |
| 2025 | -51.4 million USD | 486000 USD |
VTGN
Price: $0.58
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.90 USD
P/E Ratio: -0.33
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 11.3 million
Ebitda: -2.8 millionMarket Capitalization: 18.4 million